NAT14 antibody (N-Term)
Quick Overview for NAT14 antibody (N-Term) (ABIN953608)
Target
See all NAT14 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 12-41, N-Term
-
Specificity
- This antibody recognizes Human and Mouse NAT14 (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 12-41 amino acids from the N-terminal region of Human NAT14.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NAT14 (N-Acetyltransferase 14 (GCN5-Related, Putative) (NAT14))
-
Alternative Name
- NAT14
-
Background
- Synonyms: EC 2.3.1, K562 cell-derived leucine-zipper-like protein 1, KLP1, N-acetyltransferase 14, NAT14
-
Molecular Weight
- 21650 Da
-
Gene ID
- 57106
-
NCBI Accession
- NP_065111
-
Pathways
- SARS-CoV-2 Protein Interactome
Target
-